8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Labcorp Reaffirms 2026 Guidance and Sets 2029 Growth Outlook
Filed with the SEC on · Summarized by InvestorsBot
At its September 10, 2026 Investor Day, Labcorp reaffirmed 2026 guidance for revenue of $14.71 billion to $14.83 billion, adjusted EPS of $18.10 to $18.55, and free cash flow of $1.24 billion to $1.36 billion. Through 2029, the company expects annual revenue growth of 5% to 8%, adjusted EPS growth of 8.5% to 11.5%, free cash flow growth in line with adjusted earnings, and 75 to 150 basis points of adjusted operating-margin expansion, supported by specialty diagnostics, biopharma services, technology, and planned capital deployment.